Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
HanAll Biopharma Reports Q3 2024 Financial Results and Provides Business Update 2024-11-01 19:00
Senhwa Biosciences Announces the Appointment of Dr. Yiu-Lian Fong, the Former Global Head of Janssen Diagnostic Innovation and R&D at Johnson & Johnson as the New Corporate Director 2024-11-01 15:28
PharmaResearch Hosts 5th Global Symposium on 'Rejuran' 2024-11-01 14:01
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combination as First-Line Therapy for Biliary Tract Tumors, Compared to Durvalumab 2024-11-01 11:34
CARsgen® U.S. Clinical Holds Lifted by FDA 2024-11-01 09:33
Formosa Pharmaceuticals and DÁVI Farmacêutica Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Post-Operative Inflammation and Pain 2024-10-31 21:36
The One-Year Outcome of LuX-Valve Plus TRAVEL II Study was Officially Released at TCT 2024 2024-10-31 21:00
Ping An Health Achieves WONCA International Quality Dual Certifications Defining New Standards in Internet Healthcare Services 2024-10-31 20:14
Medera Announces Publication of Study Utilizing Machine Learning to Enhance Next-Generation Drug Screening with Human mini-Heart Technology 2024-10-31 20:00
I-Mab to Release Q3 2024 Financial Results on November 14, 2024 2024-10-31 19:00
Cancer trial: retraining immune cells offers new hope for patients in personalized medicine breakthrough 2024-10-31 18:00
ZYMFENTRA® (infliximab-dyyb) coverage continues to increase through partnership with top 3 Pharmacy Benefit Managers (PBMs) 2024-10-31 14:31
Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC 2024-10-31 12:02
MGI's DNBSEQ-T20 x2 Selected As A Special Mention In TIME Best Inventions 2024 2024-10-31 10:51
Abionic's CAPSULE PSP Receives FDA Approval for Early Detection of Sepsis; Fapon Introduces Exclusive PSP Solution in China via Licensing Collaboration 2024-10-31 10:26
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combined with Ligufalimab (CD47) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Compared to Pembrolizumab 2024-10-31 08:46
Neurophet partners with Beijing LADO Technology… Intends to establish Joint Venture in China 2024-10-30 21:00
I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024 2024-10-30 19:00
World Stroke Congress | TASTE-2 significantly reduces stroke disability 2024-10-30 15:36
Pulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care 2024-10-30 14:00
1 3 4 5 6 7 431